Shinpoong Pharmaceutical Co.,Ltd (KRX:019170)

South Korea flag South Korea · Delayed Price · Currency is KRW
10,410
+160 (1.56%)
Last updated: Apr 8, 2026, 2:26 PM KST
Market Cap547.15B +27.4%
Revenue (ttm)234.68B +6.1%
Net Income8.83B
EPS172.00
Shares Out51.26M
PE Ratio60.87
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume79,949
Average Volume69,055
Open10,490
Previous Close10,250
Day's Range10,270 - 10,540
52-Week Range6,400 - 20,500
Beta1.27
RSI43.50
Earnings DateMay 14, 2026

About KRX:019170

Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; woun... [Read more]

Sector Healthcare
Founded 1962
Employees 809
Stock Exchange Korea Stock Exchange
Ticker Symbol 019170
Full Company Profile

Financial Performance

Financial Statements